Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2011; 17(38): 4289-4297
Published online Oct 14, 2011. doi: 10.3748/wjg.v17.i38.4289
Published online Oct 14, 2011. doi: 10.3748/wjg.v17.i38.4289
Figure 3 Detection of p53 expression in gastric cancer cells with immunohistochemistry.
A: Untreated SGC-7901 cells; B: SGC-7901 cells treated with 5 × 109 vp/mL rAd-p53 plus 3.2 μg/mL oxaliplatin (OXA); C: Untreated BGC-823 cells; D: BGC-823 cells treated with 5 × 109 vp/mL rAd-p53 plus 3.2 μg/mL OXA; E: Untreated HGC-27 cells untreated; F: HGC-27 cells treated with 5 × 109 vp/mL rAd-p53 plus 3.2 μg/mL OXA.
- Citation: Chen GX, Zheng LH, Liu SY, He XH. rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy. World J Gastroenterol 2011; 17(38): 4289-4297
- URL: https://www.wjgnet.com/1007-9327/full/v17/i38/4289.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i38.4289